Someone pointed me to this post by “Neuroskeptic”:
A new paper in the prestigious journal PNAS contains a rather glaring blooper. . . . right there in the abstract, which states that “three neuropeptides (β-endorphin, oxytocin, and dopamine) play particularly important roles” in human sociality. But dopamine is not a neuropeptide. Neither are serotonin or testosterone, but throughout the paper, Pearce et al. refer to dopamine, serotonin and testosterone as ‘neuropeptides’. That’s just wrong. A neuropeptide is a peptide active in the brain, and a peptide in turn is the term for a molecule composed of a short chain of amino acids. Neuropeptides include oxytocin, vasopressin, and endorphins – which do feature in the paper. But dopamine and serotonin aren’t peptides, they’re monoamines, and testosterone isn’t either, it’s a steroid. This isn’t a matter of opinion, it’s basic chemistry.
The error isn’t just an isolated typo: ‘neuropeptide’ occurs 27 times in the paper, while the correct terms for the non-peptides are never used.
Neuroskeptic speculates on how this error got in:
It’s a simple mistake; presumably whoever wrote the paper saw oxytocin and vasopressin referred to as “neuropeptides” and thought that the term was a generic one meaning “signalling molecule.” That kind of mistake could happen to anyone, so we shouldn’t be too harsh on the authors . . .
The authors of the papers work in a psychology department so I guess they’re rusty on their organic chemistry.
Fair enough; I haven’t completed a chemistry class since 11th grade, and I didn’t know what a peptide is, either. Then again, I’m not writing articles on peptides for the National Academy of Sciences.
But how did this get through the review process? Let’s take a look at the published article:
Ahhhh, now I understand. The editor is Susan Fiske, notorious as the person who opened the gates of PPNAS for the articles on himmicanes, air rage, and ages ending in 9. I wonder who were the reviewers of this new paper. Nobody who knows what a peptide is, I guess. Or maybe they just read it very quickly, flipped through to the graphs and the conclusions, and didn’t read a lot of the words.
Did you catch that? Neuroskeptic refers to “the prestigious journal PNAS.” That’s PPNAS for short. This is fine, I guess. Maybe the science is ok. Based on a quick scan of the paper, I don’t think we should take a lot of the specific claims seriously, as they seem to based on the difference between “significant” and “non-significant.”
In particular, I’m not quite sure what is their support for the statement from the abstract that “each neuropeptide is quite specific in its domain of influence.” They’re rejecting various null hypotheses but I don’t know that this is supporting their substantive claims in the way that they’re saying.
I might be missing something here—I might be missing a lot—but in any case there seem to be some quality control problems at PPNAS. This should be no surprise: PPNAS is a huge journal, publishing over 3000 papers each year.
On their website they say, “PNAS publishes only the highest quality scientific research,” but this statement is simply false. I can’t really comment on this particular paper—it doesn’t seem like “the highest quality scientific research” to me, but, again, maybe I’m missing something big here. But I can assure you that the papers on himmicanes, air rage, and ages ending in 9 are not “the highest quality scientific research.” They’re not high quality research at all! What they are, is low-quality research that happens to be high-quality clickbait.
OK, let’s be fair. This is not a problem unique to PPNAS. The Lancet publishes crap papers, Psychological Science published crap papers, even JASA and APSR have their share of duds. Statistical Science, to its eternal shame, published that Bible Code paper in 1994. That’s fine, it’s how the system operates. Editors are only human.
But, really, do we have to make statements that we know are false? Platitudes are fine but let’s avoid intentional untruths.
So, instead of “PNAS publishes only the highest quality scientific research,” how about this: “PNAS aims to publish only the highest quality scientific research.” That’s fair, no?
P.S. Here’s a fun little graphics project: Redo Figure 1 as a lineplot. You’ll be able to show a lot more comparisons much more directly using lines rather than bars. The current grid of barplots is not the worst thing in the world—it’s much better than a table—but it could be much improved.
P.P.S. Just to be clear: (a) I don’t know anything about peptides so I’m offering no independent judgment of the paper in question; (b) whatever the quality is of this particular paper, does not affect my larger point that PPNAS publishes some really bad papers and so they should change their slogan to something more accurate.
P.P.P.S. The relevant Pubpeer page pointed to the following correction note that was posted on the PPNAS site after I wrote the above post but before it was posted:
The authors wish to note, “We used the term ‘neuropeptide’ in referring to the set of diverse neurochemicals that we examined in this study, some of which are not peptides; dopamine and serotonin are neurotransmitters and should be listed as such, and testosterone should be listed as a steroid. Our usage arose from our primary focus on the neuropeptides endorphin and oxytocin. Notwithstanding the biochemical differences between these neurochemicals, we note that these terminological issues have no implications for the significance of the findings reported in this paper.”